TNK BIOTECH ApS: Financial statements 2018
CVR: 30691911
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
TNK BIOTECH ApS (CVR 30691911) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 6,070 and a net result of DKK 3,168 compared with DKK -13,840 the year before. Equity in the 2018 report amounted to DKK 25,844. The solvency ratio was 31.7%.
- Gross Profit
- DKK 6,070
- Profit/Loss
- DKK 3,168
- Equity
- DKK 25,844
- Total Assets
- DKK 81,628
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 6 t. | 3 t. | 26 t. | - |
| 2017 | - | -10 t. | -14 t. | 23 t. | - |
| 2016 | - | -10 t. | -11 t. | 37 t. | - |
| 2015 | - | -32 t. | -41 t. | 48 t. | - |
| 2014 | - | -8 t. | -11 t. | 88 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
TNK BIOTECH ApS has published its annual report for 2017. Gross profit came to DKK -9,523, and the net result was DKK -13,840.
About TNK BIOTECH ApS
TNK BIOTECH ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2007. The company is registered under the industry Investering for egen regning. The company was previously named TNK INVEST ApS. The management consists of Thomas Nitschke Kledal. The company is owned by Thomas Nitschke Kledal. The company has 0 employees (2013). In 2025, the company reported a gross profit of DKK -11,363 and a net result of DKK -17,528 compared with DKK -15,724 the year before. Equity in the 2025 report amounted to DKK -82,154.